Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus - EADV | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
EADV
2018
Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus
Document
Analyser ce document
